Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Non-Current Assets

    Back to Balance Sheet
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Assets ₹5,630 Cr₹5,881 Cr₹6,840 Cr₹7,115 Cr₹6,709 Cr

What is the latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS is ₹5,630 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Assets
Mar2025₹5,630 Cr
Mar2024₹5,881 Cr
Mar2023₹6,840 Cr
Mar2022₹7,115 Cr
Mar2021₹6,709 Cr

How is Total Non-Current Assets of GLENMARK PHARMACEUTICALS Trending?

Years Total Non-Current Assets % Change
Mar2025 ₹5,630 Cr
-4.27
Mar2024 ₹5,881 Cr
-14.03
Mar2023 ₹6,840 Cr
-3.86
Mar2022 ₹7,115 Cr
6.04
Mar2021 ₹6,709 Cr -

Compare Total Non-Current Assets of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹59,101.1 Cr -3.4% -2% 43.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-3.4%

-2%

43.5%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses